108 related articles for article (PubMed ID: 12738906)
1. [The assessment of chemotherapy and radiation therapy effect in malignant lymphomas by computed tomography and magnetic resonance imaging].
Dobrovolskiene L; Griniūte R
Medicina (Kaunas); 2003; 39(4):372-8. PubMed ID: 12738906
[TBL] [Abstract][Full Text] [Related]
2. [The comparative role of computed tomography and magnetic resonance imaging in the diagnosis of extracapsular spread of malignant lymphomatous masses invading blood vessels].
Dobrovolskiene L; Griniûtë R
Medicina (Kaunas); 2003; 39(4):365-71. PubMed ID: 12738905
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM
Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944
[TBL] [Abstract][Full Text] [Related]
4. [Scintigraphy of lymphomatous masses using 99mTc-MIBI].
Dobrovolskiene L; Jurkiene N
Medicina (Kaunas); 2002; 38(2):151-8. PubMed ID: 12474732
[TBL] [Abstract][Full Text] [Related]
5. Treated thymic lymphoma: comparison of MR imaging with CT.
Spiers AS; Husband JE; MacVicar AD
Radiology; 1997 May; 203(2):369-76. PubMed ID: 9114090
[TBL] [Abstract][Full Text] [Related]
6. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
[TBL] [Abstract][Full Text] [Related]
9. [Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy].
Suzuki A; Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1996 May; 48(5):449-57. PubMed ID: 8672304
[TBL] [Abstract][Full Text] [Related]
10. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
Hill M; Cunningham D; MacVicar D; Roldan A; Husband J; McCready R; Mansi J; Milan S; Hickish T
J Clin Oncol; 1993 Nov; 11(11):2273-8. PubMed ID: 8229142
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
Grueneisen J; Sawicki LM; Schaarschmidt BM; Suntharalingam S; von der Ropp S; Wetter A; Ruhlmann V; Quick HH; Forsting M; Umutlu L
PLoS One; 2016; 11(6):e0157880. PubMed ID: 27327617
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of malignant lymphoma.
Vermoolen MA; Kersten MJ; Fijnheer R; van Leeuwen MS; Kwee TC; Nievelstein RA
Expert Rev Hematol; 2011 Apr; 4(2):161-71. PubMed ID: 21495926
[TBL] [Abstract][Full Text] [Related]
14. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
15. [Diseases of the lymphatic system of the head and neck region. A comparative study of MRI and CT].
Schedel H; Vogl T; Hahn D; Mees K; Peer F; Lissner J
Digitale Bilddiagn; 1988 Dec; 8(4):158-67. PubMed ID: 3208488
[TBL] [Abstract][Full Text] [Related]
16. Orbital lymphoma. Role of CT and MRI.
Flanders AE; Espinosa GA; Markiewicz DA; Howell DD
Radiol Clin North Am; 1987 May; 25(3):601-13. PubMed ID: 3495019
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian lymphoma. Findings with ultrasonography, computerized tomography and magnetic resonance].
Ferrozzi F; Catanese C; Uccelli M; Bassi P
Radiol Med; 1998 May; 95(5):493-7. PubMed ID: 9687927
[TBL] [Abstract][Full Text] [Related]
18. Primary lymphoma of bone: MRI and CT characteristics during and after successful treatment.
Mengiardi B; Honegger H; Hodler J; Exner UG; Csherhati MD; Brühlmann W
AJR Am J Roentgenol; 2005 Jan; 184(1):185-92. PubMed ID: 15615972
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
Wu X; Kellokumpu-Lehtinen PL; Pertovaara H; Korkola P; Soimakallio S; Eskola H; Dastidar P
NMR Biomed; 2011 Dec; 24(10):1181-90. PubMed ID: 21387451
[TBL] [Abstract][Full Text] [Related]
20. Current update on primary pancreatic lymphoma.
Anand D; Lall C; Bhosale P; Ganeshan D; Qayyum A
Abdom Radiol (NY); 2016 Feb; 41(2):347-55. PubMed ID: 26830418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
